Sputum periostin is a biomarker of type 2 inflammation but not airway dysfunction in asthma

Taha Al-Shaikhly; Ryan C. Murphy; Ying Lai; Charles W. Frevert; Jason S. Debley; Steven F. Ziegler; Kit Wong; Guiquan Jia; Cecile T.J. Holweg; Michael C. Peters; Teal S. Hallstrand

doi:10.1111/resp.14491

Sputum periostin is a biomarker of type 2 inflammation but not airway dysfunction in asthma

Taha Al-Shaikhly, Ryan C. Murphy, Ying Lai, Charles W. Frevert, Jason S. Debley, Steven F. Ziegler, Kit Wong, Guiquan Jia, Cecile T.J. Holweg, Michael C. Peters, Teal S. Hallstrand

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	491-494
Number of pages	4
Journal	Respirology
Volume	28
Issue number	5
DOIs	https://doi.org/10.1111/resp.14491
State	Published - May 2023

All Science Journal Classification (ASJC) codes

Pulmonary and Respiratory Medicine

Access to Document

10.1111/resp.14491

Cite this

@article{b448d49658c5450ca55e1f04847e4fb0,

title = "Sputum periostin is a biomarker of type 2 inflammation but not airway dysfunction in asthma",

author = "Taha Al-Shaikhly and Murphy, {Ryan C.} and Ying Lai and Frevert, {Charles W.} and Debley, {Jason S.} and Ziegler, {Steven F.} and Kit Wong and Guiquan Jia and Holweg, {Cecile T.J.} and Peters, {Michael C.} and Hallstrand, {Teal S.}",

note = "Funding Information: The work was supported by the National Institutes of Health (grant numbers: U19AI125378, K24AI130263 and R01HL153979). Funding Information: Taha Al‐Shaikhly has a patent MicroRNAs as Predictors of Response to Anti‐IgE Therapies in Chronic Spontaneous Urticaria pending. Charles W. Frevert, Jason S. Debley, Steven F. Ziegler, and Teal S. Hallstrand report grants from the National Institute of Health during the conduct of the study. Michael C. Peters reports grants from National Institute of Health‐NHLBI, Boeringer‐Ingelheim, Astrazeneca, Boehringer‐Ingelheim, Genentech, GlaxoSmithKline, Sanofi‐Genzyme‐Regeneron, and Teva, outside the submitted work. Kit Wong, Guiquan Jia, and Cecile T. J. Holweg are employees of Genentech. All other authors declared no conflict of interest. ",

year = "2023",

month = may,

doi = "10.1111/resp.14491",

language = "English (US)",

volume = "28",

pages = "491--494",

journal = "Respirology",

issn = "1323-7799",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Sputum periostin is a biomarker of type 2 inflammation but not airway dysfunction in asthma

AU - Al-Shaikhly, Taha

AU - Murphy, Ryan C.

AU - Lai, Ying

AU - Frevert, Charles W.

AU - Debley, Jason S.

AU - Ziegler, Steven F.

AU - Wong, Kit

AU - Jia, Guiquan

AU - Holweg, Cecile T.J.

AU - Peters, Michael C.

AU - Hallstrand, Teal S.

N1 - Funding Information: The work was supported by the National Institutes of Health (grant numbers: U19AI125378, K24AI130263 and R01HL153979). Funding Information: Taha Al‐Shaikhly has a patent MicroRNAs as Predictors of Response to Anti‐IgE Therapies in Chronic Spontaneous Urticaria pending. Charles W. Frevert, Jason S. Debley, Steven F. Ziegler, and Teal S. Hallstrand report grants from the National Institute of Health during the conduct of the study. Michael C. Peters reports grants from National Institute of Health‐NHLBI, Boeringer‐Ingelheim, Astrazeneca, Boehringer‐Ingelheim, Genentech, GlaxoSmithKline, Sanofi‐Genzyme‐Regeneron, and Teva, outside the submitted work. Kit Wong, Guiquan Jia, and Cecile T. J. Holweg are employees of Genentech. All other authors declared no conflict of interest.

PY - 2023/5

Y1 - 2023/5

UR - http://www.scopus.com/inward/record.url?scp=85150664917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85150664917&partnerID=8YFLogxK

U2 - 10.1111/resp.14491

DO - 10.1111/resp.14491

M3 - Letter

C2 - 36914406

AN - SCOPUS:85150664917

SN - 1323-7799

VL - 28

SP - 491

EP - 494

JO - Respirology

JF - Respirology

IS - 5

ER -

Sputum periostin is a biomarker of type 2 inflammation but not airway dysfunction in asthma

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this